XORTX Therapeutics XRTX
NASDAQ XRTX
$1.71 +0.01 (+0.45%)
As of: Sep 30, 2026 · 12:16 PM EDT

XORTX Therapeutics Inc. (XRTX) Capital Leases (2022 - 2026)

Updated

XORTX Therapeutics (XRTX) recorded Capital Leases of $15,056 in the quarter ended Mar 31, 2026, down 3.9% from $15,662 a year earlier and down 59.6% from the prior quarter.

Analysis

XORTX Therapeutics Inc. (XRTX) Capital Leases (2022 - 2026) Analysis & Trends

As of Dec 31, 2025, XORTX Therapeutics reported Capital Leases of $37,287, down 3.9% from the prior year.

  • Annual Capital Leases has a three-year compound annual growth rate of 48.0% (years ended Dec 2022 to Dec 2025).
  • Across earlier years, Capital Leases came in at $38,785 in the year ended Dec 31, 2024 (+237.0%), $11,510 in the year ended Dec 31, 2023 (unchanged) and $11,509 in the year ended Dec 31, 2022.
  • The figure for the quarter ended Mar 31, 2026 is the lowest quarterly Capital Leases since the quarter ended Dec 31, 2023.
  • On a year-over-year basis, Capital Leases has declined for four consecutive quarters, with growth averaging 44.3% over the last five quarters.
  • Per Business Quant, the preceding three quarters came in at $37,287 (quarter ended Dec 31, 2025), $59,094 (quarter ended Sep 30, 2025) and $80,473 (quarter ended Jun 30, 2025).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 15,056.00
Dec 31, 2025 37,287.00
Sep 30, 2025 59,094.00
Jun 30, 2025 80,473.00
Mar 31, 2025 15,662.00
Dec 31, 2024 38,785.00
Sep 30, 2024 61,468.00
Jun 30, 2024 83,706.00
Dec 31, 2023 11,510.00
Dec 31, 2022 11,483.73
API Access

XORTX Therapeutics Inc. Capital Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-leases&ticker=XRTX&period=max&api_key=YOUR_API_KEY